CAS: | 32986-56-4 | Mf: | C18H37N5O9 |
---|---|---|---|
MW: | C18H37N5O9 | Specification: | ≥98% |
Appearance: | White Powder | Purity: | 99%,99%min |
Shelf Life: | 2 Years | Grade: | Medical Grade,Phamaceutical Grade,Medicine & Tech,USP BP FCC EP |
high quality Tobramycin CAS 32986-56-4 Tobramycin powder
Product Name: | Tobramycin |
Synonyms: |
Tobramax |
CAS: | 32986-56-4 |
MF: | C18H37N5O9 |
MW: | 467.514 |
The Introductction
The Application & Function
Tobramycin is suitable for neonatal sepsis, septicemia, central nervous system infection (including meningitis), urinary and reproductive system infection, lung infection, biliary tract infection, abdominal infection (including penicillin G and methicillin-resistant strains) caused by Pseudomonas aeruginosa, Proteus (indole-positive and negative), Escherichia coli, Klebsiella, Enterobacter, Serratia and staphylococcus (including penicillin G and methicillin-resistant strains). And peritonitis), bone infections, skin and soft tissue infections (including burns), acute and chronic otitis media, sinusitis, etc. When the product is used for pseudomonas aeruginosa meningitis or ventriculitis, it can be administered intrathecally at the same time. When used for bronchial and lung infections, the product can be inhaled as an auxiliary treatment. Tobramycin is not effective in most group D streptococcal infections. For conjunctivitis, keratitis and other eye bacterial infections, especially against gentamicin-resistant gram-negative culm infection, such as severe pseudomonas aeruginosa infection.
The COA
Item | Specification | Results |
APPEARANCE | WHITE | CONFORMS |
SOLUBILITY | FREELY SOLUBLE IN CHLOROFORM;SOLUBLE IN WATER OR METHANOL; | CONFORMS |
PH | 5.0-7.2 | 6.51 |
LOSS ON DRYING | ≤4.5% | 3.10% |
RESIDUEON IGNITION | ≤2.5% | 0.281% |
HEAVY METALS | ≤20PPM | <15PPM |
TYRAMINE | ≤0.35% | 0.051% |
RELATED COMPOSITIONS | TYLOSIN A ≥80% A+B+C+D ≥95% | 93% 98% |
Conclusion | Confirm with the standard |